MA(Medical Affairs) 아웃소싱 시장 규모, 점유율, 성장 분석 : 서비스 유형별, 산업별, 최종사용자별, 지역별 - 업계 예측(2026-2033년)

Medical Affairs Outsourcing Market size was valued at USD 2.18 Billion in 2024 and is poised to grow from USD 2.48 Billion in 2025 to USD 6.87 Billion by 2033, growing at a CAGR of 13.6% during the forecast period (2026-2033).

The medical affairs outsourcing market is witnessing significant growth, propelled by the increase in clinical trials due to the rising prevalence of both communicable and non-communicable diseases. This surge in clinical activity is driving demand for medical devices and innovative drugs, heightening the need for outsourcing services. The combination of cost-efficiency and high-quality outputs from contract research organizations, along with strict regulatory demands, enhances market prospects. The pandemic has further transformed the field by accelerating virtual interactions and elevating the importance of scientific communication. As pharmaceutical and medical device industries cope with challenges like pricing pressures, outsourcing medical affairs becomes a strategic advantage. Collaborating with experienced CROs allows companies to streamline operations, improve compliance, and mitigate risks, promoting a trend toward continued outsourcing.

Top-down and bottom-up approaches were used to estimate and validate the size of the Medical Affairs Outsourcing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Medical Affairs Outsourcing Market Segments Analysis

Global Medical Affairs Outsourcing Market is segmented by service type, industry, end-user and region. Based on service type, the market is segmented into medical writing & publishing, medical monitoring, medical information, medical science liaisons (MSLS), regulatory affairs and others. Based on industry, the market is segmented into pharmaceuticals, biotechnology and medical devices. Based on end-user, the market is segmented into small & medium enterprises (SMEs) and large enterprises. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Medical Affairs Outsourcing Market

The demand for real-world evidence to validate the efficacy and safety of healthcare products is on the rise within the industry. This trend is driving the significance of medical affairs outsourcing providers, who are instrumental in the generation, analysis, and distribution of real-world data. By harnessing this information, these providers enhance the value proposition of pharmaceutical products and medical devices, ultimately supporting companies in making informed decisions and fostering trust among healthcare professionals and patients alike. The insights gained from real-world evidence are essential for demonstrating the tangible benefits and effectiveness of treatments in everyday clinical settings.

Restraints in the Medical Affairs Outsourcing Market

The Medical Affairs Outsourcing market faces obstacles related to ensuring uniform quality and adherence to internal standards and compliance obligations when delegating these functions. The reliance on external partners can create difficulties in maintaining the desired level of oversight and consistency. To address these challenges, organizations need to implement strong governance structures and monitoring systems that effectively oversee the outsourced activities. By doing so, they can better manage the associated risks and enhance the overall integrity of their medical affairs operations, ensuring that compliance and quality benchmarks are consistently met throughout the outsourcing process.

Market Trends of the Medical Affairs Outsourcing Market

The Medical Affairs Outsourcing market is witnessing a significant trend as pharmaceutical and medical device companies prioritize the utilization of real-world evidence to assert the safety, efficacy, and overall value of their products. As regulatory landscapes evolve and the demand for robust evidence intensifies, outsourcing providers have become essential in generating and analyzing real-world data. These partnerships facilitate evidence-based decision-making and enhance the quality of regulatory submissions, enabling companies to navigate the complexities of market access and stakeholder communication more effectively. This shift towards data-driven strategies positions outsourcing firms as pivotal allies in driving innovation and improving patient outcomes.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies
• Trade Analysis

Global Medical Affairs Outsourcing Market Size by Service Type & CAGR (2026-2033)

• Market Overview
• Medical Writing & Publishing
  • Clinical Trial Reports
  • Regulatory Documents
  • Scientific Publications
• Medical Monitoring
  • Safety Monitoring
  • Efficacy Monitoring
• Medical Information
  • Inquiry Handling
  • Medical Literature Review
• Medical Science Liaisons (MSLs)
  • Key Opinion Leader (KOL) Engagement
  • Scientific Communication
• Regulatory Affairs
  • Regulatory Submissions
  • Compliance Management
• Others
  • Pharmacovigilance
  • Training & Education

Global Medical Affairs Outsourcing Market Size by Industry & CAGR (2026-2033)

• Market Overview
• Pharmaceuticals
• Biotechnology
• Medical Devices

Global Medical Affairs Outsourcing Market Size by End-User & CAGR (2026-2033)

• Market Overview
• Small & Medium Enterprises (SMEs)
• Large Enterprises

Global Medical Affairs Outsourcing Market Size & CAGR (2026-2033)

• North America (Service Type, Industry, End-User)
  • US
  • Canada
• Europe (Service Type, Industry, End-User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Service Type, Industry, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Service Type, Industry, End-User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Service Type, Industry, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• ICON plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IQVIA Holdings Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• The Medical Affairs Company (TMAC) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Syneos Health, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PAREXEL International Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PPD, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Charles River Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Covance Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medpace Holdings, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pharm-Olam International (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Clinipace Worldwide (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PRA Health Sciences (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• KCR S.A. (Poland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• WuXi AppTec (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SGS S.A. (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Premier Research (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations